Agios Pharmaceuticals AGIO
Last Price
52 Week Range
$22.24 - $46.00
Next Earnings Date
Feb 12 2026 (Estimate)
Next Earnings Date
Feb 12 2026 (Est.)
Last Price
AGIO Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Agios Pharmaceuticals, Inc. | 8-K | October 30, 2025 | |
Agios Pharmaceuticals, Inc. | 10-Q | October 30, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | August 4, 2025 | |
Agios Pharmaceuticals, Inc. | 10-Q | July 31, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | July 31, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | July 8, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | June 18, 2025 | |
Agios Pharmaceuticals, Inc. | 10-Q | May 1, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | May 1, 2025 | |
Agios Pharmaceuticals, Inc. | ARS | April 25, 2025 | |
Agios Pharmaceuticals, Inc. | DEF 14A | April 25, 2025 | |
Agios Pharmaceuticals, Inc. | DEFA14A | April 25, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | February 13, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | February 13, 2025 | |
Agios Pharmaceuticals, Inc. | 10-K | February 13, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | January 13, 2025 | |
Agios Pharmaceuticals, Inc. | 8-K | January 6, 2025 | |
Agios Pharmaceuticals, Inc. | 10-Q | October 31, 2024 | |
Agios Pharmaceuticals, Inc. | 8-K | October 31, 2024 | |
Agios Pharmaceuticals, Inc. | 8-K | August 1, 2024 | |
Agios Pharmaceuticals, Inc. | 10-Q | August 1, 2024 | |
Agios Pharmaceuticals, Inc. | 8-K | June 20, 2024 | |
Agios Pharmaceuticals, Inc. | 8-K | May 28, 2024 | |
Agios Pharmaceuticals, Inc. | 8-K | May 2, 2024 | |
Agios Pharmaceuticals, Inc. | 10-Q | May 2, 2024 | |
Agios Pharmaceuticals, Inc. | DEFA14A | April 26, 2024 | |
Agios Pharmaceuticals, Inc. | DEF 14A | April 26, 2024 | |
Agios Pharmaceuticals, Inc. | ARS | April 26, 2024 | |
Agios Pharmaceuticals, Inc. | 8-K | February 15, 2024 | |
Agios Pharmaceuticals, Inc. | 10-K | February 15, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.